Infection Control Apparel Market to Grow with a CAGR of 4.50% through 2030
Surge in research and development activities is
expected to drive the Global Infection Control Apparel Market growth in the
forecast period, 2026-2030.
According to TechSci Research report, “Infection
Control Apparel Market - Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2030F”, the Global Infection Control Apparel
Market stood at USD 17.31 Billion in 2024 and is anticipated to grow with a
CAGR of 4.50% through 2030. Initiatives taken by government based on infection control
apparel has led to favorable market conditions for the Global Infection Control
Apparel Market. Several factors contribute to the growth of various infection control
apparel products.
A notable driver of growth in the global infection
control apparel market is the surge in research and development (R&D)
activities aimed at enhancing the performance, safety, and sustainability of
protective garments. As healthcare systems worldwide place increasing emphasis
on infection prevention and occupational safety, there is a growing demand for
apparel that not only meets regulatory standards but also provides superior
comfort, durability, and resistance to biological hazards. This has prompted
manufacturers, academic institutions, and industry stakeholders to invest
heavily in the development of innovative materials and design technologies.
One of the key areas of focus has been the formulation and enforcement of stringent regulatory guidelines for the production, certification, and usage of infection control garments. Regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and similar bodies in Asia and other regions have implemented strict protocols to ensure that gowns, masks, gloves, and other PPE meet established safety and performance criteria. These measures have prompted manufacturers to enhance the quality and compliance of their products to meet international benchmarks.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Infection Control Apparel Market”
The Global Infection Control Apparel Market is
segmented into product, end use, regional distribution, and company.
Based on Product, Lab Coats have emerged
as the dominating segment in the Global Infection Control Apparel Market in 2024.
This is due to their broad applicability, frequent usage, and essential role in
ensuring basic infection prevention across diverse professional settings. Worn
widely in hospitals, diagnostic laboratories, research institutions,
pharmaceutical manufacturing units, and even academic environments, lab coats
serve as a first line of defense against contamination by providing a
protective barrier between the user’s clothing and infectious agents. Their
dominance is largely attributed to the fact that lab coats are not limited to
high-risk procedures but are used on a daily basis by a wide range of
healthcare and laboratory personnel. This routine use results in high volume
demand and consistent procurement across both public and private sectors.
Based on Region, Asia Pacific have emerged as the fastest
growing region in the Global Infection Control Apparel Market in 2024. This is due
to a combination of rising healthcare investments, increasing awareness of
infection prevention, and the expansion of medical infrastructure across
developing economies. Countries such as China, India, Indonesia, and Vietnam
are witnessing significant growth in healthcare spending, driven by government
initiatives aimed at strengthening public health systems and reducing the
burden of hospital-acquired infections (HAIs). The region’s large and growing
population, coupled with high patient volumes and an increasing prevalence of
infectious diseases, has amplified the demand for protective apparel in
hospitals, clinics, and diagnostic centers.
Major companies operating in Global Infection Control
Apparel Market are:
- 3M Company
- DuPont de Nemours, Inc.
- Cardinal Health, Inc.
- Owens & Minor, Inc.
- Medline Industries, Inc.
- Lindström Group
- Ansell Ltd
- Delta Plus Group
- Lakeland Industries Inc.
- Protective Industrial Products, Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“One of the most prominent applications is the
incorporation of antimicrobial nanoparticles, such as silver, copper oxide, and
zinc oxide, into fabric matrices. These nanoparticles exhibit strong
bactericidal and virucidal properties, effectively disrupting the cellular
membranes of pathogens and reducing the risk of surface contamination. As a
result, infection control garments embedded with such nano-enabled agents offer
self-sanitizing capabilities, which are particularly valuable in high-risk
environments like intensive care units and surgical theaters. Furthermore,
nanofibers and nanostructured membranes are being used to develop advanced
filtration layers in gowns, coveralls, and face masks. These nanomaterials
allow for enhanced breathability without compromising barrier protection,
significantly improving user comfort during extended use”, said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Infection Control Apparel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Isolation Gowns, Chemotherapy Gowns, Lab Coats, Jackets), By End Use (Hospitals, Ambulatory & Surgical Centers, Clinics, Research & Diagnostic Labs, Others), By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Infection Control Apparel Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Infection Control Apparel Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com